Order Article Reprints

Egan KP, Awasthi S, Tebaldi G, Hook LM, Naughton AM, Fowler BT, Beattie M, Alameh M-G, Weissman D, Cohen GH, et al. A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1. Viruses. 2023; 15(7):1483. https://doi.org/10.3390/v15071483

Egan, Kevin P., Sita Awasthi, Giulia Tebaldi, Lauren M. Hook, Alexis M. Naughton, Bernard T. Fowler, Mitchell Beattie, Mohamad-Gabriel Alameh, Drew Weissman, Gary H. Cohen, and et al. 2023. "A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1" Viruses 15, no. 7: 1483. https://doi.org/10.3390/v15071483

Egan, K. P., Awasthi, S., Tebaldi, G., Hook, L. M., Naughton, A. M., Fowler, B. T., Beattie, M., Alameh, M.-G., Weissman, D., Cohen, G. H., & Friedman, H. M. (2023). A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1. Viruses, 15(7), 1483. https://doi.org/10.3390/v15071483